酒石酸卡巴拉汀
- 网络Rivastigmine;rivastigmine tartrate
酒石酸卡巴拉汀-
酒石酸卡巴拉汀是一种乙酰胆碱酯酶抑制剂，用于治疗中、轻度老年痴呆症（即阿尔茨海默氏症：AD），目前已在瑞士上市，市场前景看好。
Rivastigmine , a sort of acetylcholinesterase inhibitor , is used in the symptomatic treatment of mild to moderate Alzheimer 's Disease ( AD ) . Now it has been launched in Switzerland , and the market prospect is very good .
-
脑卒中VD组服用胆碱酯酶抑制剂重酒石酸卡巴拉汀，半年后复查头颅MRI、磁共振波谱分析（MRS）及认知功能。
The patients with VD were prescribed rivastigmine hydrogen tartrate (" Exelon ", Norvatis ), and given MRS assessment half a year later .